to test the efficacy of using low-cost nuclear magnetic resonance technologies to detect malaria parasites. The team will examine blood samples to detect hemozoin, a waste product of malarial parasites, to determine the presence of infection.
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
